Nissui Corporation TSE:1332
Nissui : Financial Statements (August 5, 2025) Supplemental Documents
Source: MarketScreener
Note: In the third quarter of FY2024, the provisional accounting treatment for a business combination at an equity-method affiliate was finalized. Accordingly, comparisons and analyses with the first quarter reflect the
August 5th 2025 Nissui Corporation effects of this finalized accounting treatment.
© Nissui All Rights Reserved.
2
Operating profit increased by approximately 6%, driven by a significant improvement in the aquaculture business and North American processing, as well as continued strong performance in international Marine Products and Food Products Business, and the domestic chilled foods business. Although ordinary profit and below declined due to a retrospective adjustment of the previous year’s figures with an impact of approximately 2.1 billion JPY, the overall progress is in line with the full-year plan.
(Unit: 100 million JPY) | 1Q of FY2024 | 1Q of FY2025 | Y-on-Y | |
(%) | ||||
Net Sales | 2,206 | 2,254 | 48 | 2.2 |
Operating Profit | 97 | 102 | 5 | 5.7 |
Ordinary Profit | 116 | 102 | (13) | (11.7) |
Profit attributable to owners of parent | 73 | 65 | (8) | (11.7) |
of FY2024 Figures>
Due to the recognition of gain on negative goodwill arising from an acquisition by an equity-method affiliate, figures for the previous fiscal year have been retrospectively adjusted.
(Unit: 100 million JPY) | 1Q of FY2024 | ||
Before adjustment | After adjustment | Y-on-Y | |
Net Sales | 2,206 | 2,206 | 0 |
Operating Profit | 97 | 97 | 0 |
Ordinary Profit | 95 | 116 | 21 |
Profit attributable to owners of parent | 52 | 73 | 20 |
(Unit: 100 million JPY) | 1Q of FY2024 | 1Q of FY2025 | Y-on-Y | |
(Amount) | (%) | |||
Net Sales | 2,206 | 2,254 | 48 | 2.2 |
Marine Products | 855 | 864 | 8 | 0.9 |
Food Products | 1,226 | 1,287 | 60 | 5.0 |
Fine Chemicals | 35 | 31 | (4) | (12.6) |
General Distribution | 39 | 40 | 0 | 1.9 |
Others | 48 | 31 | (16) | (34.4) |
Operating Profit | 97 | 102 | 5 | 5.7 |
Marine Products | 20 | 31 | 11 | 56.6 |
Food Products | 87 | 88 | 0 | 0.7 |
Fine Chemicals | 2 | 0 | (2) | (91.9) |
General Distribution | 6 | 5 | (0) | (14.3) |
Others | 1 | 0 | (1) | (67.5) |
Common Costs | (21) | (23) | (1) | 8.6 |
Ordinary Profit | 116 | 102 | (13) | (11.7) |
Profit attributable to owners of parent | 73 | 65 | (8) | (11.7) |
Food Products Business sales increased in the chilled business, where sales to
convenience stores were strong.
Significant profit growth in the Marine Products Business due to improvements in fishery, aquaculture, and North American processing. In the Food Products Business, domestic performance struggled due to higher rice prices but was offset by strong results in the chilled food business and overseas business, maintaining profit levels comparable to the 1Q of FY2024.
(Unit: 100 million JPY)
Marine Products
Fishery & Aquaculture (Except for South American Aquaculture)
Including the adjustment
(2)
of unrealized profits
Marine Products
South American Aquaculture
Including the adjustment
of unrealized profits
Marine Products
Processing & Trading
Food Products Fine Chemicals Common Costs
(Including consolidation
adjustments)
7 0
6
97
FY2024 1Q
Outside
Japan 14
(0)
▲0
▲2
Outside
Japan 5
102
▲6
(6)
FY2025 1Q
Japan (14) Japan (5)
The fishery segment achieved profit growth supported by steady tuna catches. The aquaculture segment increased profit due to improved
production results, driven by higher Japanese amberjack harvest volumes and favorable growth conditions for coho salmon.
Although domestic sales of functional ingredients for supplements remained strong, sales through mail-order
channels declined. Sales and profit also decreased for pharmaceutical raw materials, as shipments are concentrated in the second half of the fiscal year, resulting in lower performance in 1Q
Overseas businesses recorded higher profits thanks to sales expansion in North America and Europe.
Domestically, despite continued strong performance in the chilled products segment, profits declined due to rising rice and surimi costs.
North American processing improved significantly due to increased production of fillets and rising sales prices.
However, domestic trading profits declined due to the high cost of salmon and trout, and falling fish oil prices.
The recovery in market conditions led to higher selling prices, and profitability also improved thanks to increased survival rates resulting from measures to enhance the aquaculture environment.
.
Figures in parentheses indicate the negative change from the end of the previous fiscal year | Current Liabilities | 2,159 587 1,064 295 | (102) | ||
Current Assets 3,370 45 Cash and deposits 136 (10) Notes and accounts receivable 1,120 46 Inventory 1,937 (12) | Notes and accounts payable Short-term borrowings Accrued expenses | 23 | |||
(76) | |||||
3 | |||||
Non-current Liabilities 1,395 | 167 | ||||
Non-current Asssets | 2,984 | (38) | Long-term borrowings 1,133 | 175 | |
Property, plant and equipment Intangible assets | 1,796 162 | (13) (8) | Net Assets 2,800 Shareholder's equity 2,709 Equity Ratio As of March 43.6% ⇒ As of June 2025 2025 | (58) | |
Investment and other assets | 1,025 | (17) | (61) | ||
Total Assets | 6,355 | 6 | 42.6% | ||
Net assets decreased due to the impact of foreign exchange fluctuations.
(Unit: 100 million JPY)
(Unit: 100 million JPY) | 1Q of FY2024 | 1Q of FY2025 | Y-on-Y |
Profit before income taxes | 111 | 99 | (12) |
Depreciation & amortization | 60 | 63 | 3 |
Working capital | (20) | (47) | (26) |
Others | (126) | (87) | 37 |
Net cash provided by operating activities | 26 | 28 | 1 |
Investment in (Purchase of) property, plant, and equipment | (67) | (91) | (24) |
Others | (14) | (1) | 11 |
Net cash used in investing activities | (80) | (93) | (13) |
Increase or decrease in borrowings | 138 | 117 | (20) |
Others | (46) | (57) | (10) |
Net cash provided by financing activities | 91 | 59 | (31) |
Cash and cash equivalent at end of term | 237 | 177 |
Operating Cash Flow was the same level as 1Q of FY2024.
Unit: 100 million JPY | 1Q of FY2024 | 1Q of FY2025 | Y-on-Y | |
(Amount) | (%) | |||
Net Sales | 855 | 864 | 8 | 0.9 |
Operating Profit | 20 | 31 | 11 | 56.6 |
1,000
Net sales
(Quarterly)
(Unit: 100 million JPY)
FY2024
FY2025
40
Operating Profit
Marine Products Business Net Sales & Operating Profit (Y-on-Y)Growth in South American aquaculture and North American processing, along with steady
international trading business, helped offset weak domestic trading.
(Quarterly)
(Unit: 100 million JPY)
FY2024 FY2025
30
800
20
600
10
400
1Q 2Q 3Q 4Q
0
1Q 2Q 3Q 4Q
Marine Products Business Net Sales & Operating Profit (Y-on-Y)Aquaculture profit increased, due to improved aquaculture performance and higher sales prices. The
North American processing contributed to offsetting the struggles in the domestic trading business.
Operating Profit
(Bar Chart)
(Unit: 100 million JPY)
Net Sales
(Line Chart)
207
* Italic figures at the bottom of the graph are total operating income figures by function.
194
(0)
4
0
18
27 27
850
889
53
55
(Unit: JPY/kg)
<Domestic market price of salmon/trout calculated based on Trade Statistics of Japan, Ministry of Finance>
35 1,400
30 1,200
25 1,000
20 800
15 600
10 400
5 200
0 0
(5) (200)
(10) (400)
(15) (600)
FY2024 FY2025 Fishery | FY2024 FY2025 Aquaculture | FY2024 FY2025 Processing/ Trading | FY2024 FY2025 Consolidated Adjustment |
(20) (800)
Unit: 100 million JPY | 1Q of FY2024 | 1Q of FY2025 | Y-on-Y | |
(Amount) | (%) | |||
Net Sales | 1,226 | 1,287 | 60 | 5.0 |
Operating Profit | 87 | 88 | 0 | 0.7 |
1,400
Net Sales
(Quarterly)
(Unit: 100 million JPY)
Operating Profit
(Unit: 100 million JPY)
(Quarterly)
FY2024 FY2025
1,200
1,000
800
600
400
1Q 2Q 3Q 4Q
Food Products Business Net Sales & Operating Profit (Y-on-Y)Sales grew thanks to CVS promotions, while profit held steady year-on-year due
to rising rice and surimi costs.
(Unit: 100 million JPY)
Operating Profit
(Bar Chart)
Net Sales
(Line Chart)
1,066
1,052
Others Europe
North America
Japan
* Italic figures at
the bottom of the
graph are total operating income figures by
function.
327
266
80 1,600
(Unit: JPY/kg)
<Transition of import price of frozen surimi>
Based on the Trade Statistics of Japan, Ministry of Finance
70 1,400
60 1,200
50 1,000
40 800
30 600
20 400
10 200
0
(10)
75 69 13 20
0
(200)
FY2024 FY2025
Processing
FY2024 FY2025
Chilled
FY2024 FY2025
Consolidated Adjustment
Food Products Business Net Sales & Operating Profit (Y-on-Y)Profit increased overseas thanks to expanding the market share in North America and area expansion in Europe. In Japan, the chilled foods business benefited from successful CVS
initiatives, which helped offset the impact of rising rice and surimi costs.
Unit: 100 million JPY | 1Q of FY2024 | 1Q of FY2025 | Y-on-Y | |
(Amount) | (%) | |||
Net Sales | 35 | 31 | (4) | (12.6) |
Operating Profit | 2 | 0 | (2) | (91.9) |
Sales of pharmaceutical raw materials are planned to be concentrated in the second half of
the fiscal year, resulting in a decline in sales and profit in the first quarter.
Net Sales
(Quarterly) FY2024 FY2025
60
(Unit: 100 million JPY)
Operating Profit
(Quarterly)
(Unit: 100 million JPY)
FY2024 FY2025
8
40 6
4
20
2
0
1Q 2Q 3Q 4Q
0
(2)
1Q 2Q 3Q 4Q
Unit: 100 million JPY | 1Q of FY2024 | 1Q of FY2025 | Y-on-Y | |
(Amount) | (%) | |||
Net Sales | 39 | 40 | 0 | 1.9 |
Operating Profit | 6 | 5 | (0) | (14.3) |
Profit declined due to an increase in personnel expenses stemming from workforce
expansion and wage revisions, as well as a rise in electricity costs.
Net Sales
(Quarterly)
FY2024 FY2025
45
(Unit: 100 million JPY)
12
Operating Profit
(Quarterly)
(Unit: 100 million JPY)
FY2024
FY2025
40 8
35 4
30
1Q 2Q 3Q 4Q
0
1Q 2Q 3Q 4Q
Outlook/Initiatives14
(Unit: 100 million JPY) | FY2024 | FY2025 Plan | ||
Y-o-Y | (%) | |||
Net Sales | 8,861 | 9,000 | 138 | 1.6 |
Operating Profit | 317 | 345 | 27 | 8.6 |
Ordinary Profit | 353 | 355 | 1 | 0.6 |
Profit attributable to owners of parent | 253 | 250 | (3) | (1.5) |
FY2025 1Q | |
Actual | Progress Rate(%) |
2,254 | 25.1 |
102 | 29.8 |
102 | 28.9 |
65 | 26.0 |
The initiatives set out in GOOD FOODS Recipe2—expand the international business, advance the aquaculture business, and improve the profitability of underperforming
businesses—are progressing as planned, in fact at a pace slightly ahead of target.
Average operating profit
<Operating Profit Trends>
Operating Profit Trends – Marine Products and Food ProductsThe Marine Products Business primarily handles raw material sales, and the Food Products Business focuses on finished product sales and is complementary. Their combined operating profit has expanded to a level exceeding the 10-year average by 10 billion JPY. As the Marine Products Business increasingly shifts toward processed products, the boundary between the two businesses is becoming less distinct,
diminishing the significance of discussing them separately.
(Unit: 100 million JPY; after consolidation adjustments; excluding corporate expenses)
(Marine Products+ Food Products) 25.7billion JPY
EPS (Earnings Per Share) (Unit: JPY)
Synergies between the Marine Products and Food Products Businesses contributed to a steady improvement in net profit. EPS reached a record high for four consecutive years through FY2024, and with the continued share repurchase in FY2025, it is projected to
set another new high.
*After reflecting the effect
of share repurchase
Initiatives: Marine Products Business (Aquaculture business)To further expand the Aquaculture Business, we will focus on strengthening seed
production and expanding farming areas.
ーCoho salmon: to adapt to environmental changes, diversify farming
areas to hedge risk, and drive business expansion.
Japanese amberjack: accelerate the shift to large fish cages, boosting landings and improving operational efficiency.
ーJapanese amberjack, coho salmon: By enhancing seed quality—such as promoting growth, increasing heat tolerance,
and reducing disease risk at the mature stage—we aim to improve aquaculture performance, leading to higher productivity and expanded production.
(Japanese amberjack) Consolidating into submersible cages 18× larger for efficiency
(Coho salmon) Expansion of hatchery facilities
(Coho salmon) Expanding bases mainly in Iwate Prefecture
Development and Expansion in Iwate
Improving profitability through reduced feed costs
ーFishmeal & fish oil prices have eased since late 2024, and the cost for future farmed fish landings are expected to decline.
350
300
250
200
150
<Domestic Marine Products Market Conditions : Fish Oil & Fishmeal>
(Calculated based on Trade Statistics of Japan, Ministry of Finance)
(Unit: JPY/kg)
Fish meal (Peru) Fish oil (Chile)
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May
2024 2025
18
© Nissui All Rights Reserved.
Initiatives: Marine Products Business (North American Processing)The profit improvement of the North American processing business is progressing
steadily.
ーProfit improvement through increased fillet production ratio
Raising the production ratio of fillets, which maintain a higher and stable market price compared to surimi, by approximately 10%.
ーStrengthening cooperation with fishing vessels
Establishing an efficient raw material transport
system to ensure timely procurement, thus
contributing to higher product value through stable quality of Alaska pollock raw materials.
ーCost control
Reducing labor costs through efficient plant
operations and optimized workforce allocation.
4.50
4.00
3.50
3.00
2.50
2.00
1.50
1.00
0.50
アラスカすりみ
アラスカフィレ
Worker Hourly Wage Trends>
Unit price of surimi and
fillet (USD/kg)
Surimi Fillet
Worker hourly wage
trend (USD/hour)
18.06
15.85
17.15 16.85
9.84
10.50
12.19
12.36
1 3 5 7 9 11 1 3 5 7 9 11 1 3 5 7 9 11 1 3 5 7 9 11 1 3 5 7 9 11 1 3 5 7 9 11 1 3 5 7 9 11 1 3 5
2018
2019
2020
2021
2022
2023
2024
2025
0.00
Initiatives: Food Products Business (International)Actively investing in expanding overseas businesses, progressing according to plan.
(Europe/North America) Reduction of logistics costs through increased production capacity and efficiency improvements.
<Europe>
<North America>ーThe facility building has been completed, and efforts are underway to expand production lines with operations
targeted to begin in the first half of 2026.
ー Being adjacent to the cold storage facility enables reduced distribution costs and improved logistics efficiency.
ーStrengthening profitability through production capacity expansion, automation, and improved distribution efficiency.
ー Aiming to start production in September 2025.
Initiatives: Food Products Business (Japan)We will develop products emphasizing for individual, convenience, and health to
effectively meet customer needs.
Health
For individual, Convenience
Frozen food that can be
easily eaten in the microwave
Dinner side dishes for refrigerated temperature zone sales floor
Longer shelf life compared to common chilled foods
Bar-type products that can be eaten with one hand
(Kitakyushu City, Fukuoka Prefecture) *Scheduled completion in December 2026
Strengthen competitive product categories, such as frozen foods, through
technological innovation and the enhancement of production capabilities.
Toward the future vision for domestic food factories: Establish a model plant of “Nissui Smart Factory”
(*A factory that enhances Nissui’s corporate value by creating four types of value—economic, environmental, social, and human capital—through production)
Challenge
Responding to customer needs and strengthening strategic categories
Loss of existing frozen food plants / capacity shortages
Factory aging
Solution
ー Strengthening development capabilities and improving production efficiency by consolidating the production of
frozen foods and fish sausage products.
ーRealizing human- and planet-friendly production sites by optimizing production using cutting-edge technologies
such as AI, securing human resources, and reducing
environmental impact.
Toward mid-to-long-term value creation: Building a production structure that meets for individual, convenience, and health needs
*Note: The Tobata Plant and Kitakyushu Nissui Second Plant will be closed after relocation.
Initiatives: Fine Chemicals BusinessWe will expand sales of high-purity EPA for pharmaceuticals in Japan, Europe,
Asia
and Asia.
Amarin’s Sales Status in Europe
In Sales: 10 countries
Other countries are in Progress.
Maximizing sales opportunities in Europe
Sales Status
●: In Sale
Country/Region | Mochida Pharmaceutical | Amarin |
Thailand | In Sale | In Progress |
China | In Progress | In Sale |
Vietnam | Preparing for Sale | In Progress |
ASEAN & South Korea | In Progress | In Progress |
Taiwan | In Progress | ー |
●: In Progress
Japan
We expect renewed sales expansion driven by increasing demand for new dosage forms and growth in sales of AG*.
Europe
Regain market share in Japan
In June 2025, one of our existing pharmaceutical customers will enter into an exclusive licensing and supply agreement with a sales company(Recordati) specializing in cardiovascular diseases. Further expansion is expected going forward.
AG (*): Authorized Generic→ Generic pharmaceuticals manufactured and sold under authorization from the original pharmaceutical manufacturers.
We will work to enhance the value chain resilience and strive towards the long-term vision of becoming a leading company that delivers friendly foods both for people and the earth, “GOOD FOODS 2030.”
Disclaimer Regarding Forward-Looking StatementsThis presentation contains forward-looking statements regarding Nissui’s business projections for the current term and future terms. All forward-looking statements are based on the rational judgment of management derived from the information currently available, and the Company provides no assurances that these projections will be achieved.
Please be advised that the actual business performance may differ from these business projections due to changes in various factors. Significant factors affecting the actual business performance include but are not limited to the changes in the market economy and product demand, foreign exchange rate fluctuations, and amendments to various international and Japanese systems and laws.
Accordingly, please use the information contained in this presentation at your discretion. The Company assumes no liability for any losses that may arise due to the use of this presentation.
Nissui Corporation Code: 1332
Corporate Strategic Planning & IR Department
+81-3-6206-7037
https://www.nissui.co.jp/english/index.html
Appendix26
The assessment of the fish in stock were stable year-on-year.
(Unit: 100 million JPY)
20
※1 Assumed profit of pre-shipmentfish
(resident fish) in the stock
※2 Adjust unrealized profits in inventory
10
1
0
7
(1)
1
(5)
(10)
(1)
(3)
(5)
he assessment gain/loss of the fish in stock (IFRS) ※1 |
Profit/loss on the business |
Adjustment of unrealized profit ※2 |
T<Chile Trout HG Market Price>
(Unit: USD/kg)
▲10
FY24 1Q
<Breakdown of the Assessment>
FY25 1Q
(Unit: 100 million JPY) | FY2024 1Q | FY2025 1Q |
Return to the beginning balance | 22 | (3) |
The assessment gain/loss at the ending balance | (23) | 2 |
The assessment gain/loss of the fish in stock | (1) | (1) |
(HG: Fish that its head and guts removed)
Consumer Price Index
(The Ministry of Internal Affairs and Communications Index: 2020 = 100)
(Unit:100 million JPY)
(Unit:100 million JPY)
Sales by main species of Non-consolidated
Trends in Food Prices
Domestic Seafood Market: Fresh Tuna
Sales by categories of Non-consoldiated
Calculated based on Tokyo Central Wholesale
Market statistics.
(Unit : JPY/kg)
(Unit: 100 million JPY) | 1Q of FY2024 | 1Q of FY2025 | Y-o-Y | Main causes of fluctuations |
Net Sales | 2,206 | 2,254 | 48 | |
Gross Profit | 358 | 377 | 18 | |
SGA Expenses | 261 | 274 | 13 | |
Operating Profit | 97 | 102 | 5 | |
Non-operating profit | 27 | 8 | (18) | Investment income on equity method(16) Exchange gain(2) |
Non-operating expenses | 8 | 8 | 0 | |
Ordinary Profit | 116 | 102 | (13) | |
Extraordinary profit | 0 | 0 | (0) | |
Extraordinary losses | 5 | 3 | (1) | |
Profit before income taxes | 111 | 99 | (12) | |
Income taxes - current | 25 | 25 | (0) | |
Income taxes - deferred | 9 | 4 | (4) | |
Profit | 76 | 70 | (6) | |
Profit attributable to non-controlling interests | 3 | 5 | 1 | |
Profit attributable to owners of parent | 73 | 65 | (8) |
(Before Consolidated adjustment) in the 1st Quarter of FY2025
Impact of Currency Translation (Net Sales), Exchange Rates
Exchange rate among overseas subsidiaries | 1Q of FY2024 | 1Q of FY2025 | Y-on-Y | Breakdown (Unit:100 million JPY) | ||||
Local Currency | JPY (100 million) | Local Currency | JPY (100 million) | Local Currency | JPY (100 million) | Local Currency | Impact of exchange rate | |
USD (million) | 410 | 617 | 438 | 663 | 28 | 46 | 42 | 4 |
EUR (million) | 112 | 183 | 117 | 187 | 4 | 4 | 8 | (3) |
DKK (million) | 780 | 170 | 878 | 187 | 97 | 17 | 21 | (4) |
Other Currencies | — | 101 | — | 105 | — | 4 | 3 | 1 |
Total | 1,072 | 1,144 | 71 | 74 | (2) | |||
1Q of FY2024 | 1Q of FY2025 | Variation | |
USD | 150.21 JPY | 151.21 JPY | 0.7% |
EUR | 162.65 JPY | 159.35 JPY | (2.0%) |
DKK | 21.85 JPY | 21.36 JPY | (2.2%) |
Note: The foreign exchange rate in the right table is the average.